Initiator Pharma

Bifogade filer

Initiator Pharma to attend J.P. Morgan Healthcare Conference in San Francisco

2025-12-23 08:31:00

Initiator Pharma A/S, a clinical-stage biotech company, today announced it will attend J.P. Morgan Healthcare Conference January 12-15, 2026. Initiator Pharma’s CEO Claus Olesen will be available for meetings at the conference.

“The J.P. Morgan Healthcare Conference is one of the most important meeting places for the global pharmaceutical industry. It marks the starting point of 2026, a very significant year for Initiator Pharma, as we will conduct our proof-of-concept study with pudanfensine for vulvodynia during the year. For our business development, the conference in San Francisco is extremely valuable — not only in relation to this study, but also with regard to our highly advanced programs in erectile dysfunction,” says Claus Olesen, CEO of Initiator Pharma.

If you are interested in meeting with Initiator Pharma in San Francisco, please contact ir@initiatorpharma.com.

About Initiator Pharma

Initiator Pharma A/S is a Danish clinical stage emerging pharma company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system. Initiator Pharma’s pipeline consists of two clinical stage assets – pudafensine and IP2018 – and one preclinical asset. With pudafensine the company has reported positive, statistically significant and clinically relevant efficacy data in a Phase IIb clinical trial with patients suffering from ED. With IP2018 the company has reported positive, statistically significant, and dose-dependent clinical observations related to efficacy in psychogenic erectile dysfunction (ED) in a Phase IIa clinical trial of IP2018 in patients with mild to moderate ED.

Initiator Pharma is listed on Nasdaq First North Growth Market (ticker: INIT). Redeye AB is the company’s Certified Adviser. For more information, please visit www.initiatorpharma.com.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Initiator Pharma

Bifogade filer

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden